Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

08. März 2021 11:31 ET | Quelle: State Employees' Credit Union (SECU)

SECU Foundation Provides $500,000 Challenge Grant for My Kid’s Club Facility in Selma, NC

RALEIGH, N.C., March 08, 2021 (GLOBE NEWSWIRE) -- My Kid’s Club (MKC), a Johnston County non-profit seeking to raise campaign funds for a new facility to benefit underserved youth, has gained the...
04. März 2021 09:15 ET | Quelle: BioSig Technologies, Inc.

BioSig Awarded U.S. Patent Claims for its NeuroClear™ Subsidiary

Westport, CT, March 04, 2021 (GLOBE NEWSWIRE) -- The patent is exclusively licensed from Mayo Foundation for Medical Education and Research Claims address methods and materials for improving the...
18. Februar 2021 12:15 ET | Quelle: Signal Hill Road Publishing, LLC

Dr. Mae Jemison, First Woman of Color in Space, Releases Young Adult Autobiography FIND WHERE THE WIND GOES: Moments From My Life 2nd Edition on February 23rd in Time for Black History Month and Women’s History Month

Houston, TX, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Dr. Mae Jemison is already in the history books: NASA astronaut, first woman of color in space, physician in developing countries, engineer, educator,...
16. Februar 2021 08:45 ET | Quelle: BioSig Technologies, Inc.

BioSig Appoints Brenda Castrodad to Lead Human Resources

Westport, CT, Feb. 16, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...
12. Februar 2021 07:05 ET | Quelle: Myriad Genetics, Inc.

New Study from Leading University of Utah Radiation Oncologist Validates Ability of Myriad Genetics’ Prolaris® test to Guide Treatment for Prostate Cancer

SALT LAKE CITY, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced today additional data further validating the...
10. Februar 2021 10:00 ET | Quelle: BioSig Technologies, Inc.

Major Medical Centers Enter into Installation Agreements for Evaluation of BioSig PURE EP™ Systems

Westport, CT, Feb. 10, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...
10. Februar 2021 01:05 ET | Quelle: Logical Clocks

Tech for Good: Artificial Intelligence Applications that will Improve the Environment and Healthcare in the EU

Stockholm, Sweden, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Logical Clocks announces three new research projects part of the European Union (EU) Horizon 2020 research and innovation programme that will...
08. Februar 2021 07:05 ET | Quelle: Myriad Genetics, Inc.

GeneSight Psychotropic Test’s Combinatorial Approach Proves Better than Single-Gene Testing at Predicting Patient Outcomes and Medication Blood Levels

New Analysis Published in Psychiatry Research SALT LAKE CITY, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in genetic testing and precision medicine, announced...
03. Februar 2021 08:05 ET | Quelle: Xeriant, Inc.

XERI Nano-Lubricants Demonstrate Dramatic Anti-Friction Effect in Initial Automobile Testing

Noted Improvement in Fuel Efficiency, Performance and Engine Wear.Xeriant Expects Significant Revenue, Sales Beginning in 2021 BOCA RATON, Fla., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Xeriant, Inc....
02. Februar 2021 08:00 ET | Quelle: BioSig Technologies, Inc.

BioSig and Mayo Clinic Collaborate on New R&D Program to Develop Transformative AI and Machine Learning Technologies for its PURE EP™ System

Westport, CT, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Global market for AI in healthcare is estimated to reach $45.2 billion by 2026 BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the...

Vorherige Seite

Nächste Seite